ICAM1 and melanoma: Further, decitabine could enhance antitumor efficacy of ICAM1‐ADC with multiple mechanisms, mainly including synergistically boosting anti‐tumor immunity; upregulating ICAM1 expression on melanoma cell; enhancing tumor penetration of ICAM1‐ADC.